Atorvastatin Calcium
Product Images NDC 67296-2055

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 67296-2055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-10mg-10s-blister (Atorvastatin 10mg 10s Blister)

Atorvastatin-10mg-10s-blister (Atorvastatin 10mg 10s Blister)
Atorvastatin Calcium Tablet, USP 10 mg (base) label showing the product name and strength. Distributed by Ascend Laboratories, LLC, Parsippany, NJ. Made in India. The label includes a barcode and a code number DD/DRUGS/DD/230.*
FDA Label Image

Atorvastatin-10mg-10s-cart-1 (Atorvastatin 10mg 10s Cart 1)

Atorvastatin-10mg-10s-cart-1 (Atorvastatin 10mg 10s Cart 1)
Atorvastatin Calcium Tablets USP 10 mg unit-dose packaging label by Ascend Laboratories. The label states it is for in-institution use only and contains 100 tablets (10 x 10 unit-dose). Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. The label includes storage instructions and caution to keep out of reach of children.*
FDA Label Image

Atorvastatin-10mg-90s-tab-1 (Atorvastatin 10mg 90s Tab 1)

Atorvastatin-10mg-90s-tab-1 (Atorvastatin 10mg 90s Tab 1)
Label for Atorvastatin Calcium Tablets, USP 10 mg by Ascend Laboratories, LLC. The label includes directions to store at controlled room temperature. The package contains 90 tablets for prescription use only. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, Parsippany, NJ. The label displays dosage strength, manufacturer, distributor information, and a URL for patient information.*
FDA Label Image

Atorvastatin-20mg-500s-tab-1 (Atorvastatin 20mg 500s Tab 1)

Atorvastatin-20mg-500s-tab-1 (Atorvastatin 20mg 500s Tab 1)
Label for Atorvastatin Calcium Tablets USP 20 mg, showing a bottle label for 500 tablets. The label includes storage instructions, dosage reference, manufacturer Alkem Laboratories Ltd., India, and distributor Ascend Laboratories, LLC. It features a barcode, NDC 67877-512-05, and indicates Rx only.*
FDA Label Image

Atorvastatin-40mg-1000s-tab-1. (Atorvastatin 40mg 1000s Tab 1)

Atorvastatin-40mg-1000s-tab-1. (Atorvastatin 40mg 1000s Tab 1)
Label for Atorvastatin Calcium Tablets USP showing 40 mg strength in film-coated tablet form. The label states 1000 tablets quantity, Rx only, and includes storage instructions for controlled room temperature. Manufactured by Alkem Laboratories and distributed by Ascend Laboratories, LLC. Barcode and manufacturer details present.*
FDA Label Image

Atorvastatin-80mg-1000s-tab-1 (Atorvastatin 80mg 1000s Tab 1)

Atorvastatin-80mg-1000s-tab-1 (Atorvastatin 80mg 1000s Tab 1)
Label for Atorvastatin Calcium Tablets USP 80 mg, showing a package size of 1000 tablets. The label includes storage instructions, manufacturer Alkem Laboratories Ltd., India, and distributor Ascend Laboratories, LLC, Parsippany, NJ. It also features a barcode and a note for patients to see the package insert for full prescribing information.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
A line graph depicting cumulative incidence percentage over a period of 3.5 years comparing Atorvastatin and Placebo. The solid line represents Atorvastatin showing a lower cumulative incidence than the dashed line for Placebo, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
A cumulative hazard plot showing the time to first primary endpoint over four years of follow-up, comparing Atorvastatin and placebo groups. The graph plots cumulative hazard percentage against years, with Atorvastatin represented by a solid line and placebo by a dashed line, indicating a lower cumulative hazard for Atorvastatin.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
A line graph plotting the percentage of subjects experiencing an event over time (years) to the first major cardiovascular endpoint. It compares Atorvastatin at two doses, 10 mg (dashed line) and 80 mg (solid line), over a 5-year period. The graph includes a hazard ratio (HR 0.78) with confidence interval and p-value statistics.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)
Chemical structure of Atorvastatin Calcium, depicting two of the atorvastatin molecules complexed with a calcium ion (Ca2+) and three water molecules (3H2O). The molecular diagram includes phenyl rings, hydroxyl groups, and a fluorophenyl substituent as part of the atorvastatin structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.